Hiding in Plain Sight-Could a Common Molecular Mechanism Define Neurodegenerative
暂无分享,去创建一个
[1] C. Olanow,et al. Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder? , 2013, Movement disorders : official journal of the Movement Disorder Society.
[2] N. Cairns,et al. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. , 2012, Archives of neurology.
[3] Stephen J. DeArmond,et al. Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions , 2012, Proceedings of the National Academy of Sciences.
[4] K. Jellinger,et al. Interaction between pathogenic proteins in neurodegenerative disorders , 2012, Journal of cellular and molecular medicine.
[5] M. Jucker,et al. Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders , 2011, Annals of neurology.
[6] J. Trojanowski,et al. Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline , 2010, The Journal of Neuroscience.
[7] S. Strittmatter,et al. β-amyloid oligomers and cellular prion protein in Alzheimer’s disease , 2010, Journal of Molecular Medicine.
[8] P. Westermark,et al. Fibrils from Designed Non-Amyloid-Related Synthetic Peptides Induce AA-Amyloidosis during Inflammation in an Animal Model , 2009, PloS one.
[9] John W. Gilbert,et al. Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.
[10] H. Laude,et al. Prion agent diversity and species barrier. , 2008, Veterinary research.
[11] N. Makarava,et al. Highly Promiscuous Nature of Prion Polymerization* , 2007, Journal of Biological Chemistry.
[12] Jonathan S. Weissman,et al. The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.
[13] W. Surewicz,et al. Molecular basis of barriers for interspecies transmissibility of mammalian prions. , 2004, Molecular cell.
[14] J. Griffith,et al. Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.